Therapeutic Asset Ratings
12,939 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
C-Car066
B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(46)
cd19-ucart
T-Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P1
CC
(46)
Centella Asiatica Water Extract Product
Cognitive Disorder
Oregon Health and Science University
P1
CC
(46)
CIS-DIAMMINEDICHLOROPLATINUM II
Bariatric Surgery Candidate
Alexandria University
P1
CC
(46)
Clifutinib
Childhood Acute Myeloid Leukemia
Sunshine Lake Pharma Co., Ltd.
P1
CC
(46)
cls12311 high
Relapsing-Remitting Multiple Sclerosis
Cellerys AG
P1
CC
(46)
cls12311 low
Relapsing-Remitting Multiple Sclerosis
Cellerys AG
P1
CC
(46)
cls12311 medium
Relapsing-Remitting Multiple Sclerosis
Cellerys AG
P1
CC
(46)
Cnsi-Fe
Vulva Cancer
Sichuan Enray Pharmaceutical Sciences Company
P1
CC
(46)
Cyclophosphamide
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc.
P1
CC
(46)
Cyclophosphamide
KRAS G12D
Sun Yat-sen University
P1
CC
(46)
Cyclophosphamide
KRAS G12V
Sun Yat-sen University
P1
CC
(46)
Cyclophosphamide
Malignant Urinary System Neoplasm
National Cancer Institute (NCI)
P1
CC
(46)
Cyclophosphamide
Monocytic Leukemia
Masonic Cancer Center, University of Minnesota
P1
CC
(46)
DABIGATRAN ETEXILATE
HER2 Mutation
Bayer
P1
CC
(46)
DARATUMUMAB
Monocytic Leukemia
Masonic Cancer Center, University of Minnesota
P1
CC
(46)
Dazostinag
Triple-Negative Breast Carcinoma
Takeda
P1
CC
(46)
Dcr-Stat3
Refractory Malignant Neoplasm
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
P1
CC
(46)
DNA, D(P-THIO)((2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))RA-G-G-T-G-A-A-G-M5C-G-A-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RC)
Hepatitis B Virus Infection
GlaxoSmithKline
P1
CC
(46)
Duvelisib
Plasma Cell Myeloma
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(46)
dvx201
Acute Myeloid Leukemia
Coeptis Therapeutics
P1
CC
(46)
DYNAMOS
Tuberous Sclerosis Complex (TSC)
GRIN Therapeutics, Inc.
P1
CC
(46)
Ecnoglutide
Type 2 Diabetes Mellitus
Sciwind Biosciences APAC CO Pty. Ltd.
P1
CC
(46)
Efineptakin Alfa
High Grade B-Cell Lymphoma
NeoImmuneTech
P1
CC
(46)
Eli-002 7P
Bile Duct Cancer
Elicio Therapeutics
P1
CC
(46)
Showing 601 to 625 of 12,939 assets
Previous
Page 25 of 518
Next
